Everything below concerns GHRH analog. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
Since the atomic bombings of Hiroshima and Nagasaki during the Second World War, there has been a widespread and prolonged fear of a potential third world war between nuclear-armed powers. It is often suggested that it would become a nuclear war, and be more devastating and violent than both the First and Second World Wars. Albert Einstein is often quoted as having said in 1947 "I know not with what weapons World War III will be fought, but World War IV will be fought with sticks and stones." It has been anticipated and planned for by military and civil authorities, and it has also been explored in fiction. Scenarios have ranged from conventional warfare to limited or total nuclear warfare. Various former government officials, politicians, authors, and military leaders (including James Woolsey, Alexandre de Marenches, Eliot Cohen, and Subcomandante Marcos) have attempted to apply the labels of the "Third World War" and the "Fourth World War" to various past and present global wars since the end of the Second World War, such as the Cold War and the war on terror respectively. During the early 21st century, the ongoing armed conflicts that are taking place around the world, and their worldwide spillovers are sometimes described as proxy wars waged by the United States and Russia, which led some commentators to characterize the situation as a "proto-world war", with many countries embroiled in overlapping conflicts.
== Creativity == On the Global Creativity Index for 2015, Thailand ranks 82 of 139 nations (1=best, 139=worst). Thailand's ASEAN partners were ranked: Singapore, 9; Laos, 42; Philippines, 52; Malaysia, 63; Vietnam, 80; Cambodia, 113; Indonesia, 115.
Taking an inventory of someone's refrigerator or pantry to determine the types and amounts of food they have For dental and chewing challenges, juicing or mincing fresh produce, or using canned or frozen fruits and vegetables Using nutritional supplements like a multivitamin pill (with primary care provider's approval) Clarifying with a healthcare provider if a given medication can cause loss of appetite Encouraging exercise to improve appetite and maintain bone and muscular health
Austin participated in the Royal Rumble match, where he was the last wrestler eliminated by the winner Mr. McMahon. Austin defeated McMahon St. Valentine's Day Massacre in a steel cage match, winning the championship opportunity at WrestleMania XV, where he defeated The Rock to win his third WWF Championship. Austin faced The Rock in a rematch the following month at Backlash. Austin would lose the championship to The Undertaker at Over the Edge. Due to events revolving around Vince, Stephanie and Linda McMahon made Austin the chief executive officer (CEO) of the company as part of the storyline. Vince and Shane challenged Austin to a handicap ladder match at King of the Ring with the title of CEO on the line, which the McMahons won. The next night on Raw, Austin challenged and defeated The Undertaker to win his fourth WWF Championship. The two would compete in a "First Blood" match at Fully Loaded, with the stipulation that if Austin lost he would never compete for the WWF Championship again, but if Austin won, Vince would depart the company; Austin won after interference from X-Pac.
Sources: en.wikipedia.org
The normal concentration of fibrinogen in blood plasma is 150–400 mg/dl, with levels appreciably below or above this range associated with pathological bleeding and/or thrombosis. Fibrinogen has a circulating half-life of ~4 days.
The situation regarding glycaemic control and complications in type 2 diabetes is less clear cut than for type 1, though there is evidence from the United Kingdom Prospective Diabetes Study Group that strict blood glucose control is beneficial for both microvascular and macrovascular complications. In the original study a relatively modest difference in glycaemic control between the well-controlled and less well-controlled groups resulted in a 25% lower rate of microvascular complications. In follow-up studies from the same group significant relative risk reductions emerged for myocardial infarction (15%, P=0.014) and all-cause mortality (12%, P=0.007).
wheat germ or reticulocyte extracts) Wheat germ extract contains functional ribosomes. It can be used to translate mRNA outside of a cell. Using purified membrane-bounded organelles Mitochondria and chloroplasts can be isolated from cells while preserving their function. Using purified macromolecular complexes (such as ribosomes) Functional ribosomes have been assembled in vitro. Using purified molecules (such as proteins, DNA, or RNA) Polymerase chain reaction is a method for selective replication of specific DNA and RNA sequences in the test tube. It uses pure isolated enzymes. The action of DNA replication has been analyzed in vitro on a single-molecule basis.
Psilocybin is a serotonergic psychedelic that acts as a prodrug of psilocin, the active form of the drug. Psilocin is a close analogue of the monoamine neurotransmitter serotonin and, like serotonin, acts as a non-selective agonist of the serotonin receptors, including behaving as a partial agonist of the serotonin 5-HT2A receptor. It shows high affinity for most of the serotonin receptors, with the notable exception of the serotonin 5-HT3 receptor. Psilocin's affinity for the serotonin 5-HT2A receptor is 15-fold higher in humans than in rats due to species differences. In addition to interacting with the serotonin receptors, psilocin is a partial serotonin releasing agent with lower potency. Despite the in-vitro findings, psilocybin did not show serotonin release in the brain in rodents in vivo. Unlike certain other psychedelics such as LSD, it appears to show little affinity for many other targets, such as dopamine receptors. Psilocin is an agonist of the mouse and rat but not human trace amine-associated receptor 1 (TAAR1). Psilocybin's and psilocin's psychedelic effects are mediated specifically by agonism of the serotonin 5-HT2A receptor. Selective serotonin 5-HT2A receptor antagonists like volinanserin block the head-twitch response (HTR), a behavioral proxy of psychedelic-like effects, induced by psilocybin in rodents, and the HTR is similarly absent in serotonin 5-HT2A receptor knockout mice. There is a significant relationship between psilocybin's hallucinogenic effects and serotonin 5-HT2A receptor occupancy in humans.
In the equation above, xi is the concentration of template Ii; x is the total concentration of all templates; ki is the excess production rate of template Ii, which is a difference between formation fi by self-replication of the template and its degradation di, usually by hydrolysis; ki,j is the production rate of template Ii catalysed by Ij; and φ is a dilution flux; which guarantees that the total concentration is constant. Production and degradation rates are expressed in numbers of molecules per time unit at unit concentration (xi = 1). Assuming that at high concentration x the term ki can be neglected, and, moreover, in the hypercycle, a template can be replicated only by itself and the previous member of the cycle, the equation can be simplified to:
Sources: en.wikipedia.org
where 1 and 2 represent the two components in the composite or blend. When determining if two materials will adhere it is common to compare the work of adhesion with the work of cohesion, Wcoh = 2γ. If the work of adhesion is greater than the work of cohesion, then the two materials are thermodynamically favored to adhere. Surface energies are commonly measured by contact angle methods. However, these methods are ideally designed for flat, uniform surfaces. For contact angle measurements on powders, they are typically compressed or adhered to a substrate which can effectively change the surface characteristics of the powder. Alternatively, the Washburn method can be used, but this has been shown to be affected by column packing, particle size, and pore geometry. IGC is a gas phase technique, thus is not subject to the above limitations of the liquid phase techniques. To measure the solid surface energy by IGC a series of injections using different probe molecules is performed at defined column conditions. It is possible to ascertain both the dispersive component of the surface energy and acid-base properties via IGC. For the dispersive surface energy, the retention volumes for a series of n-alkane vapors (i.e. decane, nonane, octane, heptanes, etc.) are measured. The Dorris and Gray. or Schultz methods can then be used to calculate the dispersive surface energy. Retention volumes for polar probes (i.e.
=== Type 2 diabetes === Type 2 diabetes mellitus (T2DM) and PD may involve common disease mechanisms such as mitochondrial dysfunction, insulin resistance, and oxidative stress. T2DM has been associated with an increased risk of PD and faster disease progression, in particular motor decline.
As of 2008, the United States is the leader in medical research, including pharmaceutical development. U.S. drug prices are among the highest in the world, and drug innovation is correspondingly high. In 2000, U.S.-based firms developed 29 of the 75 top-selling drugs; firms from the second-largest market, Japan, developed eight, and the United Kingdom contributed 10. France, which imposes price controls, developed three. Throughout the 1990s, outcomes were similar.
=== Production === Polystyrene is an addition polymer that results when styrene monomers polymerize (interconnect). This can be started by applying heat or benzoyl peroxide to styrene as initiators. As a liquid or a gas, pure styrene will polymerise spontaneously to polystyrene, without the need of external initiators. In the polymerization, the carbon–carbon π bond of the vinyl group is broken, and a new carbon–carbon σ bond is formed, attaching to the carbon of another styrene monomer to the chain. Since only one kind of monomer is used in its preparation, it is a homopolymer. The newly formed σ bond is stronger than the π bond that was broken, thus it is difficult to depolymerize polystyrene. About a few thousand monomers typically comprise a chain of polystyrene, giving a molar mass of 100,000–400,000 g/mol.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.